Blue Cross and Blue Shield of Illinois policy
Ustekinumab and Associated Biosimilars
Ustekinumab and Associated Biosimilars is a public Blue Cross and Blue Shield of Illinois policy (policy RX501.114, effective Jul 1, 2026). It lists 15 CPT or HCPCS codes. Not a coverage decision; the payer's own document governs.
View the original policy (PDF) ↗
- Policy number
- RX501.114
- Effective
- Jul 1, 2026
- Line of business
- Commercial, Medicaid
- Source
- medicalpolicy.hcsc.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes.
| Code | Other Blue Cross and Blue Shield of Illinois policies |
|---|---|
| C9399 | Policies naming C9399 |
| J3357 | Policies naming J3357 |
| J3358 | Policies naming J3358 |
| J3490 | Policies naming J3490 |
| J3590 | Policies naming J3590 |
| Q5098 | Policies naming Q5098 |
| Q5099 | Policies naming Q5099 |
| Q5100 | Policies naming Q5100 |
| Q5137 | Policies naming Q5137 |
| Q5138 | Policies naming Q5138 |
| Q5164 | Policies naming Q5164 |
| Q9996 | Policies naming Q9996 |
| Q9997 | Policies naming Q9997 |
| Q9998 | Policies naming Q9998 |
| Q9999 | Policies naming Q9999 |